Cargando…

Clinical Application of Botulinum Neurotoxin in Lower-Urinary-Tract Diseases and Dysfunctions: Where Are We Now and What More Can We Do?

Botulinum toxin A (Botox) had been considered a promising drug that has an effect on functional disorders of the lower urinary tract. Because Botox exhibits anti-inflammatory and antispasmodic effects, Botox injection into the bladder can decrease detrusor contractility, reduce bladder hypersensitiv...

Descripción completa

Detalles Bibliográficos
Autor principal:	Kuo, Hann-Chorng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324011/ https://www.ncbi.nlm.nih.gov/pubmed/35878235 http://dx.doi.org/10.3390/toxins14070498

Ejemplares similares

Botulinum Toxin Paves the Way for the Treatment of Functional Lower Urinary Tract Dysfunction
por: Kuo, Hann-Chorng
Publicado: (2020)

Botulinum Toxin A and Lower Urinary Tract Dysfunction: Pathophysiology and Mechanisms of Action
por: Jhang, Jia-Fong, et al.
Publicado: (2016)

Frontiers in the Clinical Applications of Botulinum Toxin A as Treatment for Neurogenic Lower Urinary Tract Dysfunction
por: Jiang, Yuan-Hong, et al.
Publicado: (2020)

Spinal cord injury and neurogenic lower urinary tract dysfunction: what do we know and where are we going?
por: Dodd, William, et al.
Publicado: (2022)

Novel Applications of OnabotulinumtoxinA in Lower Urinary Tract Dysfunction
por: Jhang, Jia-Fong, et al.
Publicado: (2018)

A Precision Urodynamic Diagnosis is Essential for Successful Treatment of Lower Urinary Tract Dysfunction
por: Kuo, Hann-Chorng
Publicado: (2022)

Videourodynamic findings of lower urinary tract dysfunctions in men with persistent storage lower urinary tract symptoms after medical treatment
por: Jiang, Yuan-Hong, et al.
Publicado: (2018)

Where are we now and where are we headed?
por: Langan, Ewan A.
Publicado: (2023)

Resistant Hypertension: Where are We Now and Where Do We Go from Here?
por: Pathan, Mansur K, et al.
Publicado: (2020)

Where are we now?
Publicado: (1977)

The evolution of lower gastrointestinal endoscopy: where are we now?
por: Sivananthan, Arun, et al.
Publicado: (2020)

Role of videourodynamic study in precision diagnosis and treatment for lower urinary tract dysfunction
por: Jiang, Yuan-Hong, et al.
Publicado: (2019)

Biliary atresia: Where do we stand now?
por: Govindarajan, Krishna Kumar
Publicado: (2016)

Mechanical Thrombectomy- Where Do We Stand Now ?
por: Chakraborty, Debabrata, et al.
Publicado: (2022)

Clinical chorioamnionitis: where do we stand now?
por: Lukanović, David, et al.
Publicado: (2023)

Co-treatment of lower urinary tract symptoms and cardiovascular disease – where do we stand?
por: Semczuk-Kaczmarek, Karolina, et al.
Publicado: (2020)

AI in medicine: Where are we now and where are we going?
por: Shandhi, Md Mobashir Hasan, et al.
Publicado: (2022)

Intrahepatic Cholangiocarcinoma—Where Are We Now and Where Are We Going to?
por: Wasilewicz, Michał P., et al.
Publicado: (2023)

Health in All policies: what do we mean and where are we now?
por: Green, L
Publicado: (2022)

Long-Term Follow-Up of Lower Urinary Tract Outcome in Children with Dysfunctional Voiding
por: Peng, Chung-Hsin, et al.
Publicado: (2022)

Respiratory Tract Oncobiome in Lung Carcinogenesis: Where Are We Now?
por: Czarnecka-Chrebelska, Karolina H., et al.
Publicado: (2023)

NIPPV: Where Are We Now?
por: Fakharian, Atefeh, et al.
Publicado: (2013)

Onchodermatitis: Where Are We Now?
por: Murdoch, Michele E.
Publicado: (2018)

Vesicoureteral Reflux: Where Have We Been, Where Are We Now, and Where Are We Going?
por: McLorie, Gordon A.
Publicado: (2008)

Correlates of Protection against Norovirus Infection and Disease—Where Are We Now, Where Do We Go?
por: Ramani, Sasirekha, et al.
Publicado: (2016)

Non-surgical management of knee osteoarthritis: where are we now and where do we need to go?
por: Buttgereit, Frank, et al.
Publicado: (2015)

Platelet-Rich Plasma: Where Are We Now and Where Are We Going?
por: Cole, Brian J., et al.
Publicado: (2010)

Aging with Down Syndrome—Where Are We Now and Where Are We Going?
por: Alldred, Melissa J., et al.
Publicado: (2021)

Immunotherapies in Genitourinary Oncology: Where Are We Now? Where Are We Going?
por: Jang, Albert, et al.
Publicado: (2021)

Ten Years for GHSP: Where Are We Now? Where Will We Go?
por: Bhutta, Zulfiqar A., et al.
Publicado: (2023)

Targeting therapy in pemphigus: Where are we now and where are we going?
por: Abulikemu, Kailibinuer, et al.
Publicado: (2023)

CAR-T cell therapy: Where are we now, and where are we heading?
por: Wang, Jia-Yi, et al.
Publicado: (2023)

Calculus detection technologies: where do we stand now?
por: Archana, V
Publicado: (2014)

Open Bankart Repair: Where do We Stand Now?
por: Kholinne, Erica, et al.
Publicado: (2019)

Immunity to Avian Leukosis Virus: Where Are We Now and What Should We Do?
por: Feng, Min, et al.
Publicado: (2016)

Articular Cartilage Repair: Where We Have Been, Where We Are Now, and Where We Are Headed
por: Grande, Daniel A., et al.
Publicado: (2013)

Comparative Medicine in the Twenty-First Century: Where are We Now and Where Do We Go from Here?
por: Mobasheri, Ali
Publicado: (2015)

The impact of ICCPR's Global Audit of Cardiac Rehabilitation: where are we now and where do we need to go?
por: Turk-Adawi, Karam, et al.
Publicado: (2023)

Video-Urodynamic Characteristics and Predictors of Switching from Botulinum Neurotoxin a Injection to Augmentation Enterocystoplasty in Spinal Cord Injury Patients
por: Lin, Chih-Chieh, et al.
Publicado: (2022)

Use of Urinary Biomarkers in Discriminating Interstitial Cystitis/Bladder Pain Syndrome from Male Lower Urinary Tract Dysfunctions
por: Yu, Wan-Ru, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vaocsd9l1sog3ihtph2e54vjob